Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study Investigating the Optimal Dose Regimen, Efficacy, and Safety of Adding Oral Cysteamine in Adult Patients Being Treated for an Exacerbation of CF-associated Lung Disease
Status: Enrolling
Updated:  12/31/1969
795
mi
from 43215
Orlando, FL
A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study Investigating the Optimal Dose Regimen, Efficacy, and Safety of Adding Oral Cysteamine in Adult Patients Being Treated for an Exacerbation of CF-associated Lung Disease
Status: Enrolling
Updated: 12/31/1969
Central Florida Pulmonary
795
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study Investigating the Optimal Dose Regimen, Efficacy, and Safety of Adding Oral Cysteamine in Adult Patients Being Treated for an Exacerbation of CF-associated Lung Disease
Status: Enrolling
Updated:  12/31/1969
515
mi
from 43215
Albany, NY
A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study Investigating the Optimal Dose Regimen, Efficacy, and Safety of Adding Oral Cysteamine in Adult Patients Being Treated for an Exacerbation of CF-associated Lung Disease
Status: Enrolling
Updated: 12/31/1969
Albany Medical College
515
mi
from 43215
Albany, NY
Click here to add this to my saved trials
A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study Investigating the Optimal Dose Regimen, Efficacy, and Safety of Adding Oral Cysteamine in Adult Patients Being Treated for an Exacerbation of CF-associated Lung Disease
Status: Enrolling
Updated:  12/31/1969
163
mi
from 43215
Morgantown, WV
A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study Investigating the Optimal Dose Regimen, Efficacy, and Safety of Adding Oral Cysteamine in Adult Patients Being Treated for an Exacerbation of CF-associated Lung Disease
Status: Enrolling
Updated: 12/31/1969
West Virginia University
163
mi
from 43215
Morgantown, WV
Click here to add this to my saved trials
A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study Investigating the Optimal Dose Regimen, Efficacy, and Safety of Adding Oral Cysteamine in Adult Patients Being Treated for an Exacerbation of CF-associated Lung Disease
Status: Enrolling
Updated:  12/31/1969
4698
mi
from 43215
Roma,
A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study Investigating the Optimal Dose Regimen, Efficacy, and Safety of Adding Oral Cysteamine in Adult Patients Being Treated for an Exacerbation of CF-associated Lung Disease
Status: Enrolling
Updated: 12/31/1969
Ospedale Padiatrico Bambino Gesu Centro Fibrosi Cistica
4698
mi
from 43215
Roma,
Click here to add this to my saved trials
A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study Investigating the Optimal Dose Regimen, Efficacy, and Safety of Adding Oral Cysteamine in Adult Patients Being Treated for an Exacerbation of CF-associated Lung Disease
Status: Enrolling
Updated:  12/31/1969
2
mi
from 43215
Columbus, OH
A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study Investigating the Optimal Dose Regimen, Efficacy, and Safety of Adding Oral Cysteamine in Adult Patients Being Treated for an Exacerbation of CF-associated Lung Disease
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital
2
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study Investigating the Optimal Dose Regimen, Efficacy, and Safety of Adding Oral Cysteamine in Adult Patients Being Treated for an Exacerbation of CF-associated Lung Disease
Status: Enrolling
Updated:  12/31/1969
335
mi
from 43215
Milwaukee, WI
A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study Investigating the Optimal Dose Regimen, Efficacy, and Safety of Adding Oral Cysteamine in Adult Patients Being Treated for an Exacerbation of CF-associated Lung Disease
Status: Enrolling
Updated: 12/31/1969
Medical College of Wisconsin/ Froedtert Hospital
335
mi
from 43215
Milwaukee, WI
Click here to add this to my saved trials
Work of Breathing During Non-invasive Ventilation in Premature Neonates
Prospective Crossover Comparison of Work of Breathing During Non-invasive Ventilation: Neurally Adjusted Ventilatory Assist (NAVA) Versus Nasal Intermittent Positive Pressure Ventilation (NIPPV) in Premature Neonates
Status: Enrolling
Updated:  12/31/1969
622
mi
from 43215
Little Rock, AR
Work of Breathing During Non-invasive Ventilation in Premature Neonates
Prospective Crossover Comparison of Work of Breathing During Non-invasive Ventilation: Neurally Adjusted Ventilatory Assist (NAVA) Versus Nasal Intermittent Positive Pressure Ventilation (NIPPV) in Premature Neonates
Status: Enrolling
Updated: 12/31/1969
Arkansas Children's Hospital
622
mi
from 43215
Little Rock, AR
Click here to add this to my saved trials
Workflow Validation of an In-home Auto-titrating Mandibular Positioner
Workflow Validation of an In-home Auto-titrating Mandibular Positioner
Status: Enrolling
Updated:  12/31/1969
2000
mi
from 43215
Bellevue, WA
Workflow Validation of an In-home Auto-titrating Mandibular Positioner
Workflow Validation of an In-home Auto-titrating Mandibular Positioner
Status: Enrolling
Updated: 12/31/1969
Premier Sleep
2000
mi
from 43215
Bellevue, WA
Click here to add this to my saved trials
A Study to Assess the Effect of CK-2127107 on Physical Function in Subjects With Chronic Obstructive Pulmonary Disease
A Phase 2a, Randomized, Double-blind, Placebo-controlled, Two Period, Crossover Study to Assess the Effect of CK-2127107 on Physical Function in Subjects With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/31/1969
1984
mi
from 43215
Torrance, CA
A Study to Assess the Effect of CK-2127107 on Physical Function in Subjects With Chronic Obstructive Pulmonary Disease
A Phase 2a, Randomized, Double-blind, Placebo-controlled, Two Period, Crossover Study to Assess the Effect of CK-2127107 on Physical Function in Subjects With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/31/1969
Site US01055
1984
mi
from 43215
Torrance, CA
Click here to add this to my saved trials
A Study to Assess the Effect of CK-2127107 on Physical Function in Subjects With Chronic Obstructive Pulmonary Disease
A Phase 2a, Randomized, Double-blind, Placebo-controlled, Two Period, Crossover Study to Assess the Effect of CK-2127107 on Physical Function in Subjects With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/31/1969
163
mi
from 43215
Pittsburgh, PA
A Study to Assess the Effect of CK-2127107 on Physical Function in Subjects With Chronic Obstructive Pulmonary Disease
A Phase 2a, Randomized, Double-blind, Placebo-controlled, Two Period, Crossover Study to Assess the Effect of CK-2127107 on Physical Function in Subjects With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/31/1969
Site US10048
163
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated:  12/31/1969
166
mi
from 43215
Indianapolis, IN
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated: 12/31/1969
Riley Children's Hospital
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated:  12/31/1969
623
mi
from 43215
Minneapolis, MN
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated: 12/31/1969
University of Minnesota Medical Center
623
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated:  12/31/1969
1153
mi
from 43215
Aurora, CO
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated: 12/31/1969
Children's Hospital Colorado
1153
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated:  12/31/1969
553
mi
from 43215
Hartford, CT
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated: 12/31/1969
Connecticut Children's Medical Center
553
mi
from 43215
Hartford, CT
Click here to add this to my saved trials
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated:  12/31/1969
671
mi
from 43215
Jacksonville, FL
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated: 12/31/1969
Nemours Children's Clinic
671
mi
from 43215
Jacksonville, FL
Click here to add this to my saved trials
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated:  12/31/1969
432
mi
from 43215
Atlanta, GA
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated: 12/31/1969
Emory University Hospital
432
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated:  12/31/1969
164
mi
from 43215
Detroit, MI
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Michigan
164
mi
from 43215
Detroit, MI
Click here to add this to my saved trials
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated:  12/31/1969
248
mi
from 43215
Grand Rapids, MI
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated: 12/31/1969
Helen DeVos Women and Childrens Center
248
mi
from 43215
Grand Rapids, MI
Click here to add this to my saved trials
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated:  12/31/1969
618
mi
from 43215
Kansas City, MO
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated: 12/31/1969
Children's Mercy Hospital
618
mi
from 43215
Kansas City, MO
Click here to add this to my saved trials
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated:  12/31/1969
296
mi
from 43215
Buffalo, NY
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated: 12/31/1969
Women and Children's Hospital of Buffalo
296
mi
from 43215
Buffalo, NY
Click here to add this to my saved trials
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated:  12/31/1969
481
mi
from 43215
New York, NY
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of New York - Columbia University Medical Center
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated:  12/31/1969
2026
mi
from 43215
Portland, OR
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
2026
mi
from 43215
Portland, OR
Click here to add this to my saved trials
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated:  12/31/1969
910
mi
from 43215
Dallas, TX
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated: 12/31/1969
U.T. Southwestern Medical Center
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated:  12/31/1969
991
mi
from 43215
Houston, TX
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated: 12/31/1969
Baylor College of Medicine
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated:  12/31/1969
590
mi
from 43215
Burlington, VT
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated: 12/31/1969
University of Vermont
590
mi
from 43215
Burlington, VT
Click here to add this to my saved trials
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated:  12/31/1969
275
mi
from 43215
Charlottesville, VA
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated: 12/31/1969
University of Virginia Health System
275
mi
from 43215
Charlottesville, VA
Click here to add this to my saved trials
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated:  12/31/1969
334
mi
from 43215
Milwaukee, WI
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated: 12/31/1969
Childrens Hospital of Milwaukee
334
mi
from 43215
Milwaukee, WI
Click here to add this to my saved trials
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated:  12/31/1969
696
mi
from 43215
Pensacola, FL
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
Status: Enrolling
Updated: 12/31/1969
Nemour's Children's Clinic
696
mi
from 43215
Pensacola, FL
Click here to add this to my saved trials
Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants 6 to 24 Months of Age
Phase I Placebo-Controlled Study of the Infectivity, Safety and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, LID cp ΔM2-2, Lot RSV#009B, Delivered as Nose Drops to RSV-Seronegative Infants 6 to 24 Months of Age
Status: Enrolling
Updated:  12/31/1969
1982
mi
from 43215
Los Angeles, CA
Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants 6 to 24 Months of Age
Phase I Placebo-Controlled Study of the Infectivity, Safety and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, LID cp ΔM2-2, Lot RSV#009B, Delivered as Nose Drops to RSV-Seronegative Infants 6 to 24 Months of Age
Status: Enrolling
Updated: 12/31/1969
David Geffen School of Medicine at UCLA NICHD CRS
1982
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants 6 to 24 Months of Age
Phase I Placebo-Controlled Study of the Infectivity, Safety and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, LID cp ΔM2-2, Lot RSV#009B, Delivered as Nose Drops to RSV-Seronegative Infants 6 to 24 Months of Age
Status: Enrolling
Updated:  12/31/1969
1154
mi
from 43215
Aurora, CO
Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants 6 to 24 Months of Age
Phase I Placebo-Controlled Study of the Infectivity, Safety and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, LID cp ΔM2-2, Lot RSV#009B, Delivered as Nose Drops to RSV-Seronegative Infants 6 to 24 Months of Age
Status: Enrolling
Updated: 12/31/1969
Univ. of Colorado Denver NICHD CRS
1154
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants 6 to 24 Months of Age
Phase I Placebo-Controlled Study of the Infectivity, Safety and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, LID cp ΔM2-2, Lot RSV#009B, Delivered as Nose Drops to RSV-Seronegative Infants 6 to 24 Months of Age
Status: Enrolling
Updated:  12/31/1969
277
mi
from 43215
Chicago, IL
Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants 6 to 24 Months of Age
Phase I Placebo-Controlled Study of the Infectivity, Safety and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, LID cp ΔM2-2, Lot RSV#009B, Delivered as Nose Drops to RSV-Seronegative Infants 6 to 24 Months of Age
Status: Enrolling
Updated: 12/31/1969
Rush Univ. Cook County Hosp. Chicago NICHD CRS
277
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants 6 to 24 Months of Age
Phase I Placebo-Controlled Study of the Infectivity, Safety and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, LID cp ΔM2-2, Lot RSV#009B, Delivered as Nose Drops to RSV-Seronegative Infants 6 to 24 Months of Age
Status: Enrolling
Updated:  12/31/1969
344
mi
from 43215
Baltimore, MD
Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants 6 to 24 Months of Age
Phase I Placebo-Controlled Study of the Infectivity, Safety and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, LID cp ΔM2-2, Lot RSV#009B, Delivered as Nose Drops to RSV-Seronegative Infants 6 to 24 Months of Age
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University Center for Immunization Research
344
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants 6 to 24 Months of Age
Phase I Placebo-Controlled Study of the Infectivity, Safety and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, LID cp ΔM2-2, Lot RSV#009B, Delivered as Nose Drops to RSV-Seronegative Infants 6 to 24 Months of Age
Status: Enrolling
Updated:  12/31/1969
414
mi
from 43215
Philadelphia, PA
Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants 6 to 24 Months of Age
Phase I Placebo-Controlled Study of the Infectivity, Safety and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, LID cp ΔM2-2, Lot RSV#009B, Delivered as Nose Drops to RSV-Seronegative Infants 6 to 24 Months of Age
Status: Enrolling
Updated: 12/31/1969
Philadelphia IMPAACT Unit CRS
414
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial
Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial
Status: Enrolling
Updated:  12/31/1969
333
mi
from 43215
Nashville, TN
Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial
Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center
333
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial
Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial
Status: Enrolling
Updated:  12/31/1969
797
mi
from 43215
New Orleans, LA
Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial
Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial
Status: Enrolling
Updated: 12/31/1969
Louisiana State University School of Medicine
797
mi
from 43215
New Orleans, LA
Click here to add this to my saved trials
Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial
Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial
Status: Enrolling
Updated:  12/31/1969
799
mi
from 43215
New Orleans, LA
Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial
Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial
Status: Enrolling
Updated: 12/31/1969
Ochsner Health System
799
mi
from 43215
New Orleans, LA
Click here to add this to my saved trials
Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial
Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial
Status: Enrolling
Updated:  12/31/1969
493
mi
from 43215
Birmingham, AL
Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial
Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
493
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial
Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial
Status: Enrolling
Updated:  12/31/1969
2006
mi
from 43215
Seattle, WA
Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial
Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial
Status: Enrolling
Updated: 12/31/1969
Harborview Medical Center at University of Washington
2006
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Avelumab for People With Recurrent Respiratory Papillomatosis
A Phase II Study of Avelumab in Subjects With Recurrent Respiratory Papillomatosis
Status: Enrolling
Updated:  12/31/1969
322
mi
from 43215
Bethesda, MD
Avelumab for People With Recurrent Respiratory Papillomatosis
A Phase II Study of Avelumab in Subjects With Recurrent Respiratory Papillomatosis
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center
322
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
A Phase 1/2 Study to Assess MultiStem® Therapy in Acute Respiratory Distress Syndrome
A Phase 1/2 Study to Assess the Safety and Efficacy of MultiStem® Therapy in Subjects With Acute Respiratory Distress Syndrome
Status: Enrolling
Updated:  12/31/1969
127
mi
from 43215
Cleveland, OH
A Phase 1/2 Study to Assess MultiStem® Therapy in Acute Respiratory Distress Syndrome
A Phase 1/2 Study to Assess the Safety and Efficacy of MultiStem® Therapy in Subjects With Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 12/31/1969
University Hospitals of Cleveland Medical Center
127
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
A Phase 1/2 Study to Assess MultiStem® Therapy in Acute Respiratory Distress Syndrome
A Phase 1/2 Study to Assess the Safety and Efficacy of MultiStem® Therapy in Subjects With Acute Respiratory Distress Syndrome
Status: Enrolling
Updated:  12/31/1969
414
mi
from 43215
Philadelphia, PA
A Phase 1/2 Study to Assess MultiStem® Therapy in Acute Respiratory Distress Syndrome
A Phase 1/2 Study to Assess the Safety and Efficacy of MultiStem® Therapy in Subjects With Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 12/31/1969
Hospital of the University of Pennsylvania
414
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
A Phase 1/2 Study to Assess MultiStem® Therapy in Acute Respiratory Distress Syndrome
A Phase 1/2 Study to Assess the Safety and Efficacy of MultiStem® Therapy in Subjects With Acute Respiratory Distress Syndrome
Status: Enrolling
Updated:  12/31/1969
165
mi
from 43215
Pittsburgh, PA
A Phase 1/2 Study to Assess MultiStem® Therapy in Acute Respiratory Distress Syndrome
A Phase 1/2 Study to Assess the Safety and Efficacy of MultiStem® Therapy in Subjects With Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh Medical Center
165
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
A Phase 1/2 Study to Assess MultiStem® Therapy in Acute Respiratory Distress Syndrome
A Phase 1/2 Study to Assess the Safety and Efficacy of MultiStem® Therapy in Subjects With Acute Respiratory Distress Syndrome
Status: Enrolling
Updated:  12/31/1969
3760
mi
from 43215
Birmingham,
A Phase 1/2 Study to Assess MultiStem® Therapy in Acute Respiratory Distress Syndrome
A Phase 1/2 Study to Assess the Safety and Efficacy of MultiStem® Therapy in Subjects With Acute Respiratory Distress Syndrome
Status: Enrolling
Updated: 12/31/1969
Queen Elizabeth Hospital
3760
mi
from 43215
Birmingham,
Click here to add this to my saved trials
Autologous Stem Cell Treatment for Chronic Lung Disease Study
Autologous Stem Cell Treatment for Chronic Lung Disease Study
Status: Enrolling
Updated:  12/31/1969
905
mi
from 43215
Dallas, TX
Autologous Stem Cell Treatment for Chronic Lung Disease Study
Autologous Stem Cell Treatment for Chronic Lung Disease Study
Status: Enrolling
Updated: 12/31/1969
Lung Institute Dallas
905
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Dose, Safety, Tolerability and Immunogenicity of a Stabilized Prefusion RSV F Subunit Protein Vaccine, VRC-RSVRGP084-00-VP (DS-Cav1), Alone or With Alum Adjuvant, in Healthy Adults
VRC 317: A Phase I Randomized, Open-Label Clinical Trial to Evaluate Dose, Safety, Tolerability and Immunogenicity of a Stabilized Prefusion RSV F Subunit Protein Vaccine, VRC-RSVRGP084-00-VP (DS-Cav1), Alone or With Alum Adjuvant, in Healthy Adults
Status: Enrolling
Updated:  12/31/1969
322
mi
from 43215
Bethesda, MD
Dose, Safety, Tolerability and Immunogenicity of a Stabilized Prefusion RSV F Subunit Protein Vaccine, VRC-RSVRGP084-00-VP (DS-Cav1), Alone or With Alum Adjuvant, in Healthy Adults
VRC 317: A Phase I Randomized, Open-Label Clinical Trial to Evaluate Dose, Safety, Tolerability and Immunogenicity of a Stabilized Prefusion RSV F Subunit Protein Vaccine, VRC-RSVRGP084-00-VP (DS-Cav1), Alone or With Alum Adjuvant, in Healthy Adults
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center
322
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of Nintedanib Over 52 Weeks in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
Status: Enrolling
Updated:  12/31/1969
511
mi
from 43215
Danbury, CT
Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of Nintedanib Over 52 Weeks in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
Status: Enrolling
Updated: 12/31/1969
Pulmonary and Sleep Specialists
511
mi
from 43215
Danbury, CT
Click here to add this to my saved trials
Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of Nintedanib Over 52 Weeks in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
Status: Enrolling
Updated:  12/31/1969
832
mi
from 43215
Brandon, FL
Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of Nintedanib Over 52 Weeks in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
Status: Enrolling
Updated: 12/31/1969
Pulmonary and Sleep of Tampa Bay
832
mi
from 43215
Brandon, FL
Click here to add this to my saved trials
Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of Nintedanib Over 52 Weeks in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
Status: Enrolling
Updated:  12/31/1969
992
mi
from 43215
Miami, FL
Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of Nintedanib Over 52 Weeks in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
Status: Enrolling
Updated: 12/31/1969
University of Miami
992
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of Nintedanib Over 52 Weeks in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
Status: Enrolling
Updated:  12/31/1969
343
mi
from 43215
Baltimore, MD
Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of Nintedanib Over 52 Weeks in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
Status: Enrolling
Updated: 12/31/1969
University of Maryland School of Medicine
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of Nintedanib Over 52 Weeks in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
Status: Enrolling
Updated:  12/31/1969
341
mi
from 43215
Towson, MD
Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of Nintedanib Over 52 Weeks in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
Status: Enrolling
Updated: 12/31/1969
Pulmonary and Critical Care Associates of Baltimore
341
mi
from 43215
Towson, MD
Click here to add this to my saved trials